On August 28–29, 2026, the 6th All-Russian Scientific and Practical Conference “Endovascular Surgery in the Treatment of Congenital and Acquired Heart Defects” took place. Raymed Group participated in one of the key professional events dedicated to the advancement of transcatheter technologies and structural heart disease.
The conference served as a platform for open communication among leading specialists, the exchange of practical expertise, and discussions on future prospects for endovascular surgery in Russia.
Focus on Advanced Technologies and Practice
The conference program featured numerous insightful presentations, discussions, and roundtables. Special emphasis was placed on contemporary approaches to the transcatheter treatment of congenital and acquired heart diseases, as well as the implementation of emerging technologies in routine clinical practice.
Keynote speakers included Academician of the Russian Academy of Sciences (RAS) A.Sh. Revishvili, T.E. Imaev, K.V. Kochkina, A.N. Fedorchenko, and many other experts. Special recognition goes to Academician of the RAS B.G. Alekyan, Chairman of the Russian Scientific Society of Endovascular Diagnostics and Treatment, through whose efforts the conference consistently convenes the field's leading authorities.
The presentations were not only highly informative, but also directly aligned with the real-world challenges currently faced by clinicians and healthcare institutions.
For Raymed Group, participating in such events is more than an opportunity to showcase our portfolio—it is, above all, direct engagement with the medical community.
Throughout the conference, we engaged extensively with physicians and specialists, discussing their current clinical priorities, institutional needs, nuances in the application of advanced equipment, and solutions that are truly in demand today. Such meetings provide invaluable insight into the market, not just from a supplier’s standpoint, but through the lens of daily clinical workflow.
The attendees themselves made a lasting impression. B.G. Alekyan and the participating physicians demonstrated profound expertise, openly sharing their experience, addressing critical issues, and candidly discussing areas that still require further development and refinement.
New Connections and Fresh Perspectives
The conference highlighted the rapid evolution currently underway in endovascular surgery. Novel technologies continue to emerge, treatment paradigms are shifting, and the scope of transcatheter interventions is expanding significantly.
What we value most is that these professional discussions are driven by tangible clinical cases and the practical needs of healthcare providers. It is precisely this collaborative exchange that uncovers new avenues for growth and guides the future trajectory of the medical device industry.
Appreciation to the Organizers and Attendees
We extend our sincere gratitude to the conference organizers, speakers, and participants for an engaging program, rich professional dialogue, and the opportunity to connect in person.
Raymed Group is proud to be part of a professional community dedicated every day to advancing cardiovascular care.
We conclude the event with valuable new partnerships, innovative ideas, and a renewed appreciation for collaboration, transparent dialogue, and continuous progress.
